NCT03952533View on ClinicalTrials.gov

α-lipoic Acid (ALA), Magnesium, Vitamin B6 and Vitamin D and Risk Factor for Pre-term Birth

NACompletedINTERVENTIONAL

Enrollment

122

Participants

Timeline

Start Date

May 5, 2019

Primary Completion Date

September 25, 2020

Study Completion Date

June 1, 2021

Conditions

Cervical ShorteningPreterm Birth

Interventions

DIETARY_SUPPLEMENT

Dav

Daily oral administration of a food supplement constituted by α-lipoic acid, magnesium, vitamin B6 and vitamin D in tablets of 1,2 g (Dav®, Lo.Li. Pharma, Rome, Italy)

Trial Locations (1)

41100

University of Modena and Reggio Emilia, Modena

All Listed Sponsors

lead

University of Modena and Reggio Emilia

OTHER

NCT03952533 - α-lipoic Acid (ALA), Magnesium, Vitamin B6 and Vitamin D and Risk Factor for Pre-term Birth | Biotech Hunter | Biotech Hunter